
Blood pressure measured as early as age seven can predict cardiovascular mortality decades later, according to a new Northwestern Medicine study published in JAMA.

Patients with newly diagnosed glaucoma who have less wealth or reside in rural communities are less likely to receive standard glaucoma care compared to wealthier patients, according to a recent multi-institution study published in JAMA Ophthalmology.

Distinguished biochemist Svetlana Mojsov, PhD, the Lulu Chow Wang and Robin Chemers Neustein Research Associate Professor at the Rockefeller University, New York, has been named the winner of the annual $250,000 Kimberly Prize in Biochemistry and Molecular Genetics.

Black adults in the U.S. are first hospitalized for heart failure nearly 14 years earlier than white adults, according to a new study analyzing data from more than 42,000 patients across hundreds of hospitals.

A new study has shed light on how a class of diabetes drugs may protect the kidneys — not just by lowering blood sugar, but by triggering a molecular shift that dampens inflammation, according to the study published in The Journal of Clinical Investigation.

Biological markers may help predict which patients will benefit most from specific therapies to treat prostate cancer, according to a study published in the journal Cell.

Northwestern Medicine scientists have developed a comprehensive atlas of genetic coding sequences in both healthy adult hearts and those with heart failure, as detailed in a recent study published in Circulation.

Feinberg faculty, trainees, students and staff gathered to explore the future of teaching and learning in medicine during the 15th Annual Medical Education Day on September 24.

Northwestern Medicine scientists have discovered that a subset of laboratory-modified T-cells can promote the repair of lung tissue damaged by viral pneumonia, according to a recent study published in The Journal of Clinical Investigation.

A research team at the Querrey Simpson Institute for Regenerative Engineering has received a four-year, $4.7 million grant to develop a system to simultaneously accelerate wound healing, lower infection risk, and provide continuous in-wound monitoring.